Abstract: Disclosed herein is a method of preventing and/or treating abnormal bone resorption and/or osteoporosis in a subject in need thereof. The method comprises administering to the subject an effective amount of an inhibitor on inhibiting neddylation. According to some embodiments of the present disclosure, the inhibitor on inhibiting neddylation is a NAE inhibitor, which includes but is not limited to, MLN4924.
Type:
Grant
Filed:
April 20, 2018
Date of Patent:
May 14, 2019
Assignees:
CHANG GUNG UNIVERSITY, CHIAYI CHANG GUNG MEMORIAL HOSPITAL
Abstract: Disclosed herein is a method of preventing and/or treating abnormal bone resorption and/or osteoporosis in a subject in need thereof. The method comprises administering to the subject an effective amount of an inhibitor on inhibiting neddylation. According to some embodiments of the present disclosure, the inhibitor on inhibiting neddylation is a NAE inhibitor, which includes but is not limited to, MLN4924.
Type:
Application
Filed:
April 20, 2018
Publication date:
October 25, 2018
Applicants:
Chang Gung University, Chiayi Chang Gung Memorial Hospital